all report title image
  • Published In : Jan 2023
  • Code : CMI1516
  • Pages : 270
  • Formats :
      Excel and PDF
  • Industry : Biotechnology
Ingographics Image

A recombinant protein is a protein encoded by recombinant DNA cloned into an expression vector that supports gene expression and translation of messenger RNA. Modification of genes by recombinant DNA techniques can result in the expression of mutant proteins. Recombinant proteins are engineered forms of natural proteins that are produced in a variety of ways to increase protein production, alter genetic sequences, and produce useful commodities.

Many recombinant proteins require and provide post-translational modifications such as glycosylation, which are only available in eukaryotic, yeast, mammalian and insect cell culture systems. HEK293-derived cell lines are used for transient protein production. Currently, most recombinant therapeutic proteins are produced in mammalian cells due to their ability to produce high quality proteins similar to those in nature. In addition, many approved recombinant therapeutic proteins have been produced in E. coli due to well-characterized genetics, rapid growth, and high-yield production.

Market Dynamics

The company is focused on adopting strategies such as acquisitions and collaborations to gain strong foothold in the global market. For instance, in December, 2021, Thermo Fischer Scientific Inc. acquired PeproTech, Inc., which is a developer and manufacturer of recombinant proteins. This acquisition will help Thermo Fischer Scientific Inc. to strengthen its recombinant proteins portfolio.

The increasing approvals for the biologics license application of recombinant hormones from the regulatory bodies is expected to drive the market growth over the forecast period. For instance, in January 2022, Pfizer Inc., a multinational pharmaceutical and biotechnology Company, and OPKO Health, Inc., a biotechnology company, announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for somatrogon. Somatrogon is an investigational once-weekly long-acting recombinant human growth hormone for the treatment of growth hormone deficiency (GHD) in pediatric patients. 

Key features of the study:

  • This report provides in-depth analysis of the global recombinant protein market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global recombinant protein market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include Merck KGaA, OriGene Technologies, Inc., Thermo Fisher Scientific Inc., Feldan Therapeutics, ACROBiosystems, Abcam plc., Randox Laboratories Ltd., SOL GROUP, Proteintech Group, Inc, Planet Biotechnology, Inc., INFINITE ENZYMES, INC., ORF Genetics, GenScript, BTL Biotechno Labs Pvt Ltd., Prospec-Tany Technogene Ltd., BPS Bioscience, Inc., Sino Biological, Cape Bio Pharms, Abnova Corporation, GeNext Genomics.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global recombinant protein market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global recombinant protein market.

Detailed Segmentation:

  • Global Recombinant Protein Market, By Product Type:
    • Antibodies
    • Antigens
    • Enzymes
    • Hormones
    • Others
  • Global Recombinant Protein Market, By Expression System:
    • Microbes
    • Plant
    • Animal
  • Global Recombinant Protein Market By Application:
    • Drug Discovery and Development
    • Research Application
    • Therapeutic Use
    • Diagnostics
    • Others
  • Global Recombinant Protein Market By End User:
    • Biotechnology and Pharmaceutical Companies
    • Academic and Research Institute
    • Contract Research Organization
    • Others
  • Global Recombinant Protein Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Merck KGaA
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • OriGene Technologies, Inc.
    • Thermo Fisher Scientific Inc.
    • Feldan Therapeutics
    • ACROBiosystems
    • Abcam plc.
    • Randox Laboratories Ltd.
    • SOL GROUP
    • Proteintech Group,Inc
    • Planet Biotechnology, Inc.
    • INFINITE ENZYMES, INC.
    • ORF Genetics
    • GenScript
    • BTL Biotechno Labs Pvt Ltd.
    • Prospec-Tany Technogene Ltd.
    • BPS Bioscience, Inc.
    • Sino Biological
    • Cape Bio Pharms
    • Abnova Corporation
    • GeNext Genomics.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Product Type
      • Market Snapshot, By Expression System
      • Market Snapshot, By Application
      • Market Snapshot, By End User
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Attractiveness Analysis
      • Market Opportunities
    • Product Launches
    • Merger, Acquisition, Collaborations
    • Regulatory Guideline and Compliances
    • Government Intervention
    • PEST Analysis
    • Technology Landscape
    • Brand Attribute Mapping
    • Investments
    • Pricing Analysis (2021)
  4. Global Recombinant Protein Market- Impact of Coronavirus (Covid-19) Pandemic
    •  Economic Impact
    • COVID-19 Epidemiology
    • Government Initiatives
  5. Global Recombinant Protein Market, By Product Type, 2017 – 2030, (US$ Million)
    • Introduction
      • Market Share Analysis, 2022 and 2030 (%)
      • Y-o-Y Growth Analysis, 2017 – 2030
      • Segment Trends
    • Antibodies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Antigens
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Enzymes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Hormones
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
  6. Global Recombinant Protein Market, By Expression System, 2017 – 2030, (US$ Million)
    • Introduction
      • Market Share Analysis, 2022 and 2030 (%)
      • Y-o-Y Growth Analysis, 2017 – 2030
      • Segment Trends
    • Microbes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Plant
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Animal
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
  7. Global Recombinant Protein Market, By Application, 2017 – 2030, (US$ Million)
    • Introduction
      • Market Share Analysis, 2022 and 2030 (%)
      • Y-o-Y Growth Analysis, 2017 – 2030
      • Segments Trends
    • Drug Discovery and Development
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Research Application
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Therapeutic Use
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Diagnostics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
  8. Global Recombinant Protein Market, By End User, 2017 – 2030, (US$ Million
    • Introduction
      • Market Share Analysis, 2022 and 2030 (%)
      • Y-o-Y Growth Analysis, 2017 – 2030
      • Segments Trends
    • Biotechnology and Pharmaceutical Companies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Academic and Research Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Contract Research Organizations
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
  9. Global Recombinant Protein Market, By Region, 2017 – 2030, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2022 and 2030 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2030
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 – 2030, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
  10. Competitive Landscape
    • Merck KGaA*
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • OriGene Technologies, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Thermo Fisher Scientific Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Feldan Therapeutics
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • ACROBiosystems
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Abcam plc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Randox Laboratories Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • SOL GROUP
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Proteintech Group, Inc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Planet Biotechnology, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • INFINITE ENZYMES, INC.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • ORF Genetics
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GenScript
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • BTL Biotechno Labs Pvt Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Prospec-Tany Technogene Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • BPS Bioscience, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Sino Biological
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Cape Bio Pharms
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Abnova Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GeNext Genomics
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
  11. Section
    • Research Methodology
    • About Us

*Browse 35 market data tables and 97 figures on “Global Recombinant Protein Market” - Global forecast to 2030

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
  • Want to Buy a Report but have a Limited Budget?

    We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

    Request Discount
Logo

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo